Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ

@arvindcanchi

Nephrologist & Transplant Physician, Bangalore/Trustwell/Sagar Hospitals | Co-Founder @Bloom_Value | Chair: @isn_india SoMe | Member- ISN SARB | #ECNeph Creator

ID: 2913871934

linkhttp://bloomvalue.com calendar_today29-11-2014 15:26:34

37,37K Tweet

10,10K Followers

1,1K Following

Trustwell Hospitals (@trustwellh) 's Twitter Profile Photo

#Kidney disease can silently damage your health, leading to severe complications if left untreated. Early detection can prevent complications, improve outcomes, and enhance your quality of life. Prioritize your kidney health with regular checkups and #expert management.

World Congress of Nephrology (@isnwcn) 's Twitter Profile Photo

WCNโ€™25 abstract submission deadline is fast approachingโ€ผ๏ธ Donโ€™t miss the chance to impact the future of kidney care by sharing your research at #ISNWCNโ€”four more days to submit your work. ow.ly/S0jU50SQgQU

WCNโ€™25 abstract submission deadline is fast approachingโ€ผ๏ธ

Donโ€™t miss the chance to impact the future of kidney care by sharing your research at #ISNWCNโ€”four more days to submit your work.

ow.ly/S0jU50SQgQU
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

FINEARTS-HF Trial ยป ๐…๐ข๐ง๐ž๐ซ๐ž๐ง๐จ๐ง๐ž ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ง๐ž๐ฐ #๐๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐›๐ฒ ๐š๐›๐จ๐ฎ๐ญ ๐š ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐ข๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ก๐ž๐š๐ซ๐ญ ๐Ÿ๐š๐ข๐ฅ๐ฎ๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ฆ๐ข๐ฅ๐๐ฅ๐ฒ ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐จ๐ซ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ซ๐ฏ๐ž๐ ๐ž๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง

FINEARTS-HF Trial
ยป ๐…๐ข๐ง๐ž๐ซ๐ž๐ง๐จ๐ง๐ž ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐ญ๐ก๐ž ๐ข๐ง๐œ๐ข๐๐ž๐ง๐œ๐ž ๐จ๐Ÿ ๐ง๐ž๐ฐ #๐๐ข๐š๐›๐ž๐ญ๐ž๐ฌ ๐›๐ฒ ๐š๐›๐จ๐ฎ๐ญ ๐š ๐ช๐ฎ๐š๐ซ๐ญ๐ž๐ซ ๐ข๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ก๐ž๐š๐ซ๐ญ ๐Ÿ๐š๐ข๐ฅ๐ฎ๐ซ๐ž ๐ฐ๐ข๐ญ๐ก ๐ฆ๐ข๐ฅ๐๐ฅ๐ฒ ๐ซ๐ž๐๐ฎ๐œ๐ž๐ ๐จ๐ซ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ซ๐ฏ๐ž๐ ๐ž๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

Hi all this is Arvind Canchi Bangalore based Nephrologist at the #NephJC. Just go onto Instagram a few weeks ago. Looking at pt education there. Follow me on Insta! Same id Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ BTW, I follow all things BP and there is this study from Norway on BP and stroke risk

Hi all this is Arvind Canchi Bangalore based Nephrologist at the  #NephJC. 
Just go onto <a href="/instagram/">Instagram</a> a few weeks ago. Looking at pt education there. Follow me on Insta! Same id <a href="/arvindcanchi/">Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ</a> 
BTW, I follow all things BP and there is this study from Norway on  BP and stroke risk
Cristina Popa (@nephroseeker) 's Twitter Profile Photo

Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ Indian Society of Nephrology ECNeph ISN Education My country is not that far. Older study, considered controlled BP if SBP < 140, but still around 20% controlled BP. HTN prevalence back then approx 40% (according to European definition of HTN) #nephjc journals.lww.com/jhypertension/โ€ฆ

<a href="/arvindcanchi/">Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ</a> <a href="/isn_india/">Indian Society of Nephrology</a> <a href="/ECNeph/">ECNeph</a> <a href="/ISNeducation/">ISN Education</a> My country is not that far. Older study, considered controlled BP if SBP &lt; 140, but still around 20% controlled BP.

HTN prevalence back then approx 40% (according to European definition of HTN)  #nephjc 
journals.lww.com/jhypertension/โ€ฆ
Arvind Canchi (Conjeevaram)๐Ÿ‡ฎ๐Ÿ‡ณ (@arvindcanchi) 's Twitter Profile Photo

๐Ÿ’ฅAnd the 2nd point, pts in a trial ate generally looked after well with a close follow up ensuring an early look at any adverse event. What about my pts, where in gonna get aggressive about BP control and I don't get to see him or her for a couple of months or more? ๐Ÿ’ฅGetting

Prachi (@prachipath123) 's Twitter Profile Photo

โญ•๏ธ49 year male โญ•๏ธ loss of vision and headache โญ•๏ธExcision of tumour โญ•๏ธAttached supportive IHC โญ•๏ธDx- ????๐Ÿ™‡โ€โ™€๏ธ๐Ÿ€๐Ÿ’š โฆDr John Hayes Jrโฉ โฆEducational Pathology Tweet Awardโฉ โฆFaisal Mahmoodโฉ โฆSanjay Mukhopadhyayโฉ โฆOlaleke Folaranmiโฉ โฆPathological Porkโฉ โฆ Peaceful Evening ahead ๐Ÿ’

โญ•๏ธ49 year male
โญ•๏ธ loss of vision and headache 
โญ•๏ธExcision of tumour 
โญ•๏ธAttached supportive IHC 
โญ•๏ธDx- ????๐Ÿ™‡โ€โ™€๏ธ๐Ÿ€๐Ÿ’š
โฆ<a href="/NeuropathyDoc/">Dr John Hayes Jr</a>โฉ โฆ<a href="/PathTweetAward/">Educational Pathology Tweet Award</a>โฉ โฆ<a href="/AI4Pathology/">Faisal Mahmood</a>โฉ โฆ<a href="/smlungpathguy/">Sanjay Mukhopadhyay</a>โฉ โฆ<a href="/DrGeeONE/">Olaleke Folaranmi</a>โฉ โฆ<a href="/PathologicalPrk/">Pathological Pork</a>โฉ โฆ
Peaceful Evening ahead ๐Ÿ’
Vinant bhargava (@vinbhargava) 's Twitter Profile Photo

๐Ÿ‘ โญ๏ธ Dr Santosh Varughese and the entire editorial team on the herculean task of releasing the online issue of PD journal of India. In the dying world of PD, itโ€™s ๐Ÿคฉ to see two of our manuscripts Peritoneal Dialysis Society India PDSI India Int. Soc. for Peritoneal Dialysis Peritoneal Dialysis International Journal Dr Prof Manisha Sahay

๐Ÿ‘ โญ๏ธ Dr Santosh Varughese and the entire editorial team on the herculean task of releasing the online issue of PD journal of India. In the dying world of PD, itโ€™s ๐Ÿคฉ to see two of our manuscripts <a href="/pdsiindia/">Peritoneal Dialysis Society India</a> <a href="/IndiaPDSI/">PDSI India</a> <a href="/ISPD1/">Int. Soc. for Peritoneal Dialysis</a> <a href="/PDI_Journal/">Peritoneal Dialysis International Journal</a> <a href="/drmanishasahay/">Dr Prof Manisha Sahay</a>
Swetha Kanduri (@swethakandurimd) 's Twitter Profile Photo

Management of Newly diagnosed MM: โ€ผ๏ธDara-VRd for standard risk โ€ผ๏ธDara- KRd for high risk as induction for transplant eligible patients โ€ผ๏ธAnti- Cd38 monoclonal antibody based quadruple induction therapy provides better response โ€ผ๏ธSaad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ American Society of Onconephrology Memorial Sloan Kettering Nephrology MSK CME

Management of Newly diagnosed MM: โ€ผ๏ธDara-VRd for standard risk 
โ€ผ๏ธDara- KRd for high risk as induction for transplant eligible patients 
โ€ผ๏ธAnti- Cd38 monoclonal antibody based quadruple induction therapy provides better response 
โ€ผ๏ธ<a href="/szusmani/">Saad Z. Usmani MD MBA FACP ๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ‡ต๐Ÿ‡ฐ</a> <a href="/onconephsociety/">American Society of Onconephrology</a> <a href="/MSK_Neph/">Memorial Sloan Kettering Nephrology</a> <a href="/MSKCME/">MSK CME</a>